Dr Reddy's Acquires Progynova, Cyclo-Progynova Brands from Mercury Pharma

robot
Abstract generation in progress

Dr. Reddy’s Laboratories Ltd. has announced the acquisition of the trademarks for Progynova and Cyclo-Progynova, along with related assets, for the Indian market from Mercury Pharma Group Limited. This strategic move marks Dr. Reddy’s entry into the hormone replacement therapy segment and strengthens its gynaecology portfolio in India. The brands, particularly Progynova, have a strong market presence with approximately ₹100 crore in sales, indicating a significant step for Dr. Reddy’s in expanding its therapeutic offerings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments